Nazia Chaudhuri

9.6k total citations · 2 hit papers
100 papers, 2.7k citations indexed

About

Nazia Chaudhuri is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Nazia Chaudhuri has authored 100 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 31 papers in Physiology and 9 papers in Rheumatology. Recurrent topics in Nazia Chaudhuri's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (65 papers), Sarcoidosis and Beryllium Toxicity Research (26 papers) and Respiratory and Cough-Related Research (19 papers). Nazia Chaudhuri is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (65 papers), Sarcoidosis and Beryllium Toxicity Research (26 papers) and Respiratory and Cough-Related Research (19 papers). Nazia Chaudhuri collaborates with scholars based in United Kingdom, United States and Germany. Nazia Chaudhuri's co-authors include Conal Hayton, Andrew Creamer, Shaney Barratt, C.T. Leonard, John Blaikley, Ian Sabroe, Richard Booton, Najib M. Rahman, J. M. Martín Martín and Janet Mills and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Nazia Chaudhuri

86 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE

2013 572 citations John Blaikley, Nazia Chaudhuri et al. Thorax profile →
Idiopathic Pulmonary Fibrosis (IPF): An Overview

2018 267 citations Shaney Barratt, Conal Hayton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nazia Chaudhuri United Kingdom	24	2.0k	572	285	242	213	100	2.7k
J. Brendan M. Mullen Canada	29	1.4k 0.7×	298 0.5×	214 0.8×	270 1.1×	188 0.9×	56	3.2k
Rosanna Vaschetto Italy	28	1.4k 0.7×	131 0.2×	191 0.7×	380 1.6×	373 1.8×	88	2.4k
Mark E. Wylam United States	26	1.5k 0.8×	772 1.3×	463 1.6×	406 1.7×	47 0.2×	74	3.0k
Nikolaos Katsikogiannis Greece	33	1.7k 0.8×	232 0.4×	128 0.4×	236 1.0×	249 1.2×	84	2.9k
Alfonso Fiorelli Italy	26	1.2k 0.6×	297 0.5×	166 0.6×	387 1.6×	245 1.2×	253	2.6k
Nikolaos Machairiotis Greece	31	1.4k 0.7×	200 0.3×	111 0.4×	220 0.9×	212 1.0×	109	2.7k
Dirk‐Jan Slebos Netherlands	37	3.8k 1.9×	645 1.1×	177 0.6×	435 1.8×	145 0.7×	237	4.6k
Won Dong Kim South Korea	27	1.8k 0.9×	638 1.1×	354 1.2×	187 0.8×	29 0.1×	106	2.3k
M Hetzel United Kingdom	29	1.7k 0.8×	988 1.7×	116 0.4×	298 1.2×	151 0.7×	74	2.9k
Theodoros Kontakiotis Greece	25	962 0.5×	321 0.6×	326 1.1×	150 0.6×	35 0.2×	93	1.7k

Countries citing papers authored by Nazia Chaudhuri

Since Specialization

Citations

This map shows the geographic impact of Nazia Chaudhuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nazia Chaudhuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nazia Chaudhuri more than expected).

Fields of papers citing papers by Nazia Chaudhuri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nazia Chaudhuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nazia Chaudhuri. The network helps show where Nazia Chaudhuri may publish in the future.

Co-authorship network of co-authors of Nazia Chaudhuri

This figure shows the co-authorship network connecting the top 25 collaborators of Nazia Chaudhuri. A scholar is included among the top collaborators of Nazia Chaudhuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nazia Chaudhuri. Nazia Chaudhuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wuyts, Wim, Francesco Bonella, Nazia Chaudhuri, et al.. (2025). Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON. Lung. 203(1). 25–25. 3 indexed citations

Fahim, Ahmed, Iain Stewart, Sarah Agnew, et al.. (2025). Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry. BMJ Open Respiratory Research. 12(1). e002773–e002773.

Assayag, Deborah, Ayodeji Adegunsoye, Yet H. Khor, et al.. (2025). Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 211(12). 2251–2267.

Cahn, Anthony, Nazia Chaudhuri, Allan Clark, et al.. (2025). The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial. BMJ Open. 15(2). e088604–e088604.

Chaudhuri, Nazia, et al.. (2024). Safety and Tolerability of Nintedanib in Patients with Fibrosing Interstitial Lung Diseases: Post-marketing Data. Advances in Therapy. 41(12). 4581–4590. 2 indexed citations

Hadinnapola, Charaka, Allan Clark, Huzaifa Adamali, et al.. (2024). Assessment of the impact of social deprivation, distance to hospital and time to diagnosis on survival in idiopathic pulmonary fibrosis. Respiratory Medicine. 227. 107612–107612. 2 indexed citations

Chaudhuri, Nazia, Laurent Navoret, C. Perrin, & Ewelina Zatorska. (2024). Hard congestion limit of the dissipative Aw–Rascle system. Nonlinearity. 37(4). 45018–45018. 2 indexed citations

Fabbri, Laura, Anne‐Marie Russell, Nazia Chaudhuri, et al.. (2024). Research priorities for progressive pulmonary fibrosis in the UK. BMJ Open Respiratory Research. 11(1). e002368–e002368.

Hayton, Conal, Waqar Ahmed, Peter S. Cunningham, et al.. (2023). Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-β1. Journal of Breath Research. 17(4). 46012–46012. 2 indexed citations

10.

Jackson, Iain, et al.. (2023). Pre-registered controlled comparison of auditory function reveals no difference between hospitalised adults with and without COVID-19. International Journal of Audiology. 63(5). 300–312. 2 indexed citations

11.

West, Alex, Nazia Chaudhuri, Adam Barczyk, et al.. (2023). Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial. Thorax. 78(9). 882–889. 35 indexed citations

12.

Mudawi, Dalia, et al.. (2021). An update on interstitial lung disease. British Journal of Hospital Medicine. 82(7). 1–14. 3 indexed citations

13.

Spencer, Lisa, et al.. (2020). Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019. ERJ Open Research. 7(1). 187–2020. 21 indexed citations

14.

Hayton, Conal, et al.. (2019). Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review. Respiratory Research. 20(1). 7–7. 25 indexed citations

15.

Chaudhuri, Nazia, et al.. (2019). The therapy of idiopathic pulmonary fibrosis: what is next?. European Respiratory Review. 28(153). 190021–190021. 187 indexed citations

16.

Barratt, Shaney, Rachel Jones, Anna Bibby, et al.. (2018). Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD). Respiratory Medicine. 135. 51–56. 4 indexed citations

17.

Rivera‐Ortega, Pilar, Conal Hayton, John Blaikley, C.T. Leonard, & Nazia Chaudhuri. (2018). Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience. Therapeutic Advances in Respiratory Disease. 12. 3270535658–3270535658. 65 indexed citations

18.

Skeoch, Sarah, Nicholas Weatherley, Andrew J. Swift, et al.. (2018). Drug induced interstitial lung disease: a systematic review. PA2244–PA2244. 21 indexed citations

19.

Richardson, Malcolm, et al.. (2016). Bagpipe lung; a new type of interstitial lung disease?. Thorax. 72(4). 380–382. 16 indexed citations

20.

Dobe, Madhumita, et al.. (1993). Utilization of maternal services in west Bengal.. PubMed. 30(3). 351–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact